Hilary Glen Selected Research

Hilary Glen Research Topics

5	Neoplasms (Cancer) 01/2022 - 08/2005
5	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 11/2015
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 08/2018
2	Disease Progression 01/2022 - 11/2015
2	Proteinuria 01/2018 - 11/2015
2	Osteosarcoma (Osteogenic Sarcoma) 07/2011 - 01/2011
1	Endometrial Neoplasms (Endometrial Cancer) 01/2022
1	Thyroid Neoplasms (Thyroid Cancer) 01/2022
1	Seminoma 01/2022
1	Febrile Neutropenia 01/2018
1	medullary Thyroid cancer 01/2018
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 01/2018
1	Carcinogenesis 10/2016
1	Myocardial Infarction 11/2015
1	Glycogen Storage Disease Type VI (Glycogenosis Type VI) 01/2011
1	Diarrhea 04/2008
1	Colonic Neoplasms (Colon Cancer) 04/2008
1	Hand-Foot Syndrome 04/2008
1	Stomatitis 04/2008
1	Neutropenia 04/2008
1	Breast Neoplasms (Breast Cancer) 01/2003

9	lenvatinibIBA 01/2022 - 01/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 11/2015
3	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2011
3	Everolimus FDA Link 01/2022 - 11/2015
2	Pharmaceutical PreparationsIBA 11/2015 - 04/2008
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Docetaxel (Taxotere)FDA Link 01/2018
1	AndrogensIBA 01/2018
1	Hormones (Hormone)IBA 01/2018
1	Tumor Biomarkers (Tumor Markers)IBA 01/2011
1	Fluorouracil (Carac)FDA LinkGeneric 04/2008
1	Leucovorin (Folinic Acid)FDA Link 04/2008
1	Capecitabine (Xeloda)FDA Link 04/2008
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2008
1	Vitamin D FDA LinkGeneric 03/2006
1	((S)- 2- (5- (1,2- dihydro- 3- methyl- 1- oxobenzo(f)- quinazoline- 9- yl)methyl)amino- 1- oxo- 2- isoindolynyl)- glutaric acidIBA 08/2005
1	Thymidylate SynthaseIBA 08/2005